← Evidence map

ArticleNature communications2025

Allogeneic iPSC-derived iNKT cells in recurrent head and neck cancer: a phase 1 trial.

Tomohisa Iinuma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41298491